Adient will participate at the Wolfe Research Global Auto and Auto Tech Conference
Adient will participate at the Wolfe Research Global Auto and Auto Tech Conference
PR Newswire
PLYMOUTH, Mich., Feb. 8, 2024
PLYMOUTH, Mich., Feb. 8, 2024 /PRNewswire/ -- Adient (NYSE: ADNT), a global leader in automotive seating, will participate at the Wolfe Research Global Auto and Auto Tech Conference on Thursday, Feb. 15, 2024. Adient's Executive Vice President and CFO Mark Oswald and Executive Vice President Americas Jim Conklin will be participating in a fireside chat at 8:20 a.m. Eastern time. A live webcast of the fireside chat will be available on the investor section of the Adient website (https://investors.adient.com/).
About Adient:
Adient (NYSE: ADNT) is a global leader in automotive seating. With 70,000+ employees in 29 countries, Adient operates more than 200 manufacturing/assembly plants worldwide. We produce and deliver automotive seating for all major OEMs. From complete seating systems to individual components, our expertise spans every step of the automotive seat-making process. Our integrated, in-house skills allow us to take our products from research and design to engineering and manufacturing — and into millions of vehicles every year. For more information on Adient, please visit www.adient.com.
ADNT-FN
SOURCE Adient
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?